Patent · US Active

Methods for prostate cancer detection and treatment

US11410748B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

Liquid Biopsy Research LLC · KN

Inventors

Irvin Mark Modlin · Woodbridge, US
Mark Kidd · New Haven, US
Ignat Drozdov · Hamilton, BM

Key dates

Filing date	Feb 21, 2019
Grant date	Aug 9, 2022
Priority date	—
Expiry date	Jan 24, 2040

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention is directed to methods for detecting a prostate cancer, methods for determining whether a prostate cancer is stable or progressive, low or high Gleason score, methods for differentiating benign prostate hyperplasia (BPH) from prostate cancer, methods for determining the completeness of surgery, and methods for evaluating the response to a prostate cancer therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.